IMVT icon

Immunovant

197 hedge funds and large institutions have $1.97B invested in Immunovant in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 82 increasing their positions, 65 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

6% less funds holding

Funds holding: 209197 (-12)

13% less capital invested

Capital invested by funds: $2.27B → $1.97B (-$300M)

29% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 35

Holders
197
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$24.3M
Puts
$23.6M
Net Calls
Net Calls Change

Top Buyers

1 +$74.7M
2 +$63.1M
3 +$42.9M
4
AC
Armistice Capital
New York
+$32.5M
5
PBA
Paradigm Biocapital Advisors
New York
+$14.9M

Top Sellers

1 -$44.7M
2 -$31.7M
3 -$27.4M
4
State Street
State Street
Massachusetts
-$24.4M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$20.4M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$554K
127
$546K
128
$537K
129
$514K
130
$479K
131
$474K
132
$467K
133
$462K
134
$453K
135
$429K
136
$428K
137
$417K
138
$416K
139
$406K
140
$405K
141
$391K
142
$376K
143
$373K
144
$358K
145
$352K
146
$334K
147
$317K
148
$295K
149
$285K
150
$279K